GlassScriptPhysician profile
Mark F Rogers
NPI 1619958345
$1,458.19
in general payments reported to CMS, 2019-2025
13 companies · $234 in 2025
The $234 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $320 · 2021: $99.70 · 2022: $26.79 · 2023: $85.70 · 2024: $257 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $577.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $582.89 | 2019-2025 | Variax, Prostep, Prostep Mica |
| Paragon 28, INC. | $295.61 | 2024-2025 | Baby Gorilla, Precision Mis Bunion, Portfolio |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $118.65 | 2019-2023 | Jublia |
| Smith+Nephew, INC. | $80.81 | 2019-2022 | |
| Nevro Corp. | $73.86 | 2021 | |
| Zyla Life Sciences, INC. | $71.23 | 2019-2020 | |
| Linvatec Corporation | $71.02 | 2023 | Colink Plating System, Allograft Tissue |
| Boston Scientific Corporation | $53.29 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Wright Medical Technology, INC. | $44.26 | 2019 | |
| Treace Medical Concepts, INC. | $33.18 | 2024-2025 | |
| Osiris Therapeutics INC. | $15.97 | 2019 | |
| Kci USA, INC. | $13.79 | 2021 | |
| Orthofix Medical, INC. | $3.63 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.